Conference Description:

The growing biotech industry has led to an increasingly competitive and saturated marketplace, and with it, greater competition for face time with premier thought leaders. Coupled with the scrutiny associated with industry partnerships and the challenges of managing KOL relationships in a post-Sunshine Act world, it is imperative for life science organizations to differentiate themselves from their competitors in the marketplace while aligning company objectives across their internal organization.

The 9th KOL/Thought Leader Engagement and Advisory Boards Summit will provide attendees with valuable insights into engaging traditional and non-traditional KOLs and discuss the priorities and motivating factors for patient groups, payers and managed care organizations. Join our esteemed faculty as they share disruptive techniques for attracting external stakeholders in meaningful ways and discuss strategies for commercial and medical groups to work together while maintaining compliance.

URLs:
Tickets: https://go.evvnt.com/216211-1?pid=154
Brochure: https://go.evvnt.com/216211-3?pid=154

Time: 8:00 am to 4:00 pm

Prices:
Conference Only - Early Bird Price Before April 27: USD 1895.0,
Conference Only - Standard Price Adter April 27: USD 2095.0

Speakers: Kevin Appareti, Senior Director, Global MSL, PHILIPS, William Soliman, Executive Chair, ACMA, Usman Iqbal, Senior Director, Medical Affairs and HEOR, TREVENA, Gail Rosen Spahn, Senior Director, Medical Sciences, XENOPORT, INC, Chijioke O. Madugwulike, Senior Manager, Clinical and Health Economics Outcomes Research, OSIRIS THERAPEUTICS, INC, Pamela Appel, Director, Strategic Support and External Engagement, Global Clinical Development and Medical Affairs, PFIZER, Joshua Corriveau, Medical Science Liaison, Dermatology/ Rheumatology, NOVARTIS, Peter Kowey, M.D., FACC, FHRS, FAHA, Professor of Medicine and Clinical Pharmacology, Jefferson Medical College, The William Wikoff Smith Chair in Cardiovascular Research, LANKENAU HOSPITAL AND MEDICAL RESEARCH CENTER, Gail Spahn, Executive Director, Scientific Affairs, ACELRX, Milijana Drobnjak, Regional Director of Sales, GILEAD SCIENCES, Natalia Borinshteyn, President, LIFE SCIENCE EXCELLENCE INC., Leslie Bloom, Director, Scientific Education and Patient Advocacy, JOHNSON AND JOHNSON, Yurek Paprocki, Medical Lead Director, NOVO NORDISK, Brandi Howard, VP, Global Clinical Development and Medical Affairs, Innovative Women's Healthcare Solutions, Amphora, EVOFEM BIOSCIENCES, Welton O'Neal, Head of Medical Affairs, SUPERNUS PHARMACEUTICALS, Vicki L. Fisher, Director, Operations and Training, Medical Affairs, JAZZ PHARMACEUTICALS